‘Tsunami of Criticism’ Follows DEA’s Proposed Telemedicine Prescribing Rules

The long-awaited proposal, unveiled in February, had been expected to ease the pathway for healthcare providers to use telemedicine to prescribe medications like buprenorphine without needing an in-person examination. But with the agency’s 30-day window for public comments expiring, the vast majority of the 20,000+ comments submitted have been negative.

Read More »